Approvals/TGA/ROTARIX human rotavirus (live attenuated oral vaccine) oral liquid tube

Approved

STANDARD

ROTARIX human rotavirus (live attenuated oral vaccine) oral liquid tube

GlaxoSmithKline Australia Pty Ltd🇦🇺 Therapeutic Goods Administration

Approval Id: bbabc60f40b0be3f
Product Name: ROTARIX human rotavirus (live attenuated oral vaccine) oral liquid tube
Artg Id: 326141
Artg Name: ROTARIX human rotavirus (live attenuated oral vaccine) oral liquid tube
Sponsor: GlaxoSmithKline Australia Pty Ltd
Company Detail Path: /organization/glaxosmithkline-australia-pty-ltd
Artg Date: 2020-02-19
Registration Type: Medicine
Therapeutic Good Type: Medicine
Licence Status: A
Licence Category: RE
Consumer Medicine Info: https://medical-cdn.nocode.com/drug_tga/c15b2cee23359207f105b2e352f4db4f.pdf
Product Information: https://medical-cdn.nocode.com/drug_tga/fb19055c14072fca484695343e0b3105.pdf

Approved

Agency

TGA

Country

🇦🇺

Approval Date

May 30, 2025

Approval ID

bbabc60f40b0be3f

Type

Standard